Plasma and CSF HVA before and after pharmacological treatment
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 28 (1) , 97-104
- https://doi.org/10.1016/0165-1781(89)90201-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Plasma Homovanillic Acid as a Predictor of Response to NeurolepticsArchives of General Psychiatry, 1988
- Plasma homovanillic acid levels and subtyping of schizophreniaPsychiatry Research, 1988
- Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primatesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- Plasma Homovanillic Acid Concentration and the Severity of Schizophrenic IllnessScience, 1985
- Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neuronesNature, 1982
- Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatmentPsychiatry Research, 1981
- CSF monoamine metabolites in depression and schizophreniaAmerican Journal of Psychiatry, 1980
- 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: Possible indicators of central dopaminergic activityEuropean Journal of Pharmacology, 1979
- Contribution of plasma homovanillic acid (HVA) to urine and cerebrospinal gluid HVA in the monkey and its pharmacokinetic dispositionLife Sciences, 1978
- The Global Assessment ScaleArchives of General Psychiatry, 1976